(2021). Correction: Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. BMJ Publishing Group.
Cita Chicago Style (17a ed.)Correction: Mechanisms Underlying Low-clinical Responses to PD-1/PD-L1 Blocking Antibodies in Immunotherapy of Cancer: A Key Role of Exosomal PD-L1. BMJ Publishing Group, 2021.
Cita MLA (8a ed.)Correction: Mechanisms Underlying Low-clinical Responses to PD-1/PD-L1 Blocking Antibodies in Immunotherapy of Cancer: A Key Role of Exosomal PD-L1. BMJ Publishing Group, 2021.
Precaución: Estas citas no son 100% exactas.